Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles
Authors:
- 6 July 2007
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 84A (3) , 598-606
Abstract
Ferrofluids are attractive candidates for magnetic targeting system because of their fluidity and magnetism. The magnetic nanoparticles in ferrofluids should have combined properties of superparamagnetic behavior, target localization, and biocompatibility. The magnetic targeting and biocompatibility of superparamagnetic iron oxide nanoparticles stabilized by alginate (SPION‐alginate) was investigated in vitro and in vivo. The localization of SPION‐alginate by an external magnetic field in vitro was quantitatively evaluated by determining the iron content, and the results revealed that the localization ratio of SPION‐alginate was 56%. Magnetic targeting of the SPION‐alginate after femoral artery administration with the magnetic field in rats was quantitatively investigated by iron content and qualitatively confirmed by histological evaluation and magnetic resonance imaging. The ratio of iron content between the target site and the nontarget site were 8.88 at 0.5 h and 7.50 at 2 h, respectively. The viability of RAW264.7 cells and L929 cells was apparently unaltered upon exposure to SPION‐alginate. The incubation with erythrocytes indicated that the SPION‐alginate did not induce erythrocytes hemolysis and aggregation. In conclusions, the SPION‐alginate had magnetic targeting with an external magnetic field and did not be detained at the injection site without the magnetic field. The SPION‐alginate was generally considered to be biocompatible in cytotoxicity and hemolysis aspects. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008Keywords
This publication has 23 references indexed in Scilit:
- Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginateInternational Journal of Pharmaceutics, 2007
- Intraarticular application of superparamagnetic nanoparticles and their uptake by synovial membrane—an experimental study in sheepJournal of Magnetism and Magnetic Materials, 2005
- Magnetically modulated therapeutic systemsInternational Journal of Pharmaceutics, 2004
- 975 A phase I/II single arm trial to determine the safety, tolerability, and biological activity of intrahepatic delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers (MTC-DOX) in patients with metastatic tumors in the liverEuropean Journal of Cancer Supplements, 2003
- Liver Ferritin Subunit Ratios in Neonatal HemochromatosisPediatric Hematology and Oncology, 2003
- A multicenter, phase I/II trial of hepatic intra-arterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocellular carcinomaEuropean Journal of Cancer, 2002
- Interaction of Anionic Superparamagnetic Nanoparticles with Cells: Kinetic Analyses of Membrane Adsorption and Subsequent InternalizationLangmuir, 2002
- Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivoGene Therapy, 2002
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Magnetic guidance of drug-carrying microspheresJournal of Applied Physics, 1978